From trusted knowledge to trustworthy clinical decision products at scale.
Deterministic. Transparent. Validated. Localized.
ProxyMed turns your trusted clinical content into executable decision functionality for your existing products, and provides the production system to create, localize, validate and maintain it at scale.
AI accelerates knowledge access. Decision-critical guidance requires a structured, validated and governed layer.
Trusted knowledge does not become trustworthy decisions by itself.
The bottleneck is not creating or accessing trusted knowledge. It is transforming the knowledge into governable trustworthy clinical decision products. Economically scalable.
Your product. Your brand. ProxyMed inside.
The output is not a separate ProxyMed application. It is executable decision functionality inside the product your customers already use.
Your trusted content
Guidelines · protocols · clinical content
Behind your UX · under your brand
Executable decision functionality inside your product
Patient-specific · transparent · maintained
Your brand, your UX, your distribution stay in front. ProxyMed supplies the executable decision capability underneath.
Start bounded: one content asset · one clinical decision use case · one production cycle.
The regulatory reality
The deep end of clinical AI is regulated. We built for it.
Patient-specific, actionable decision support in the EU is medical-device territory (MDR). Generic lookup can stay shallow — real clinical functionality cannot. ProxyMed is the infrastructure that makes deep functionality certifiable: deterministic, traceable, audit-ready by design — under your brand, within your conformity route or ours.
→ Trust & validationFor content owners
Your knowledge already earns as reference. As validated, localized decision products, it earns as software — licensed per institution, versioned per guideline cycle, carried under your brand. ProxyMed supplies the production capability; content, customers, and revenue stay yours.
As clinical decision support scales across specialties, markets and products, creating the logic is only the beginning. Validation, localization, versioning and continuous updates become an operational challenge.
Three production capabilities.
One repeatable method for transforming trusted knowledge into trustworthy clinical decision products. Adopt all three or start with one.
Complete decision context
Structured Decision Modeling defines every decision-relevant input before a recommendation is produced.
Pulmonary embolism · Assessment
Local decision relevance
A clinically correct answer can still be wrong for a specific institution or market. One shared logic, many localized models.
Localized twins, validated
A scalable production system
Every new decision product, and every new clinical domain, reuses the same production foundation.
One lifecycle, six stages
One model is craft. Thousands of models are operations.
Portfolio growth does not require proportional production effort. The clinical expertise stays domain-specific; the production foundation is reusable.
ProxyMed in practice.
Examples of our functioning decision products across specialties, each created, validated and maintained with the same method.
Emergency
Accelerating time-critical workups from initial symptom to definitive diagnosis.
See example →Dentistry
Guiding shared decision-making for complex choices like tooth preservation vs. replacement.
See example →Oncology
End-to-end guidance for diagnostic staging (cTNM) and complex therapy selection based on all relevant biomarkers.
See example →Psychiatry
Active guidance to the individually optimal approach for complex, novel psychiatric symptom combinations.
See example →Antibiotic Usage
Guiding clinicians to the individually optimal and safest antibiotic therapy, especially for multi-morbid patients with renal impairment.
See example →Sepsis
Acceleration of therapy escalation through active guidance to the individually optimal combination in the critical initial phase.
See example →One production system built, validated, and maintains all six — that is what “at scale” means.
Trust & Validation
Built for scrutiny.
A reliability layer has to survive diligence — clinical, technical, and legal. This is how ProxyMed is built to.
Validation, as a method
Every ProxyMed decision product is verified the same way, for every indication — only the epidemiology changes. Independent experts, representative cases, blind execution, measured agreement, proven reproducibility — the standard every one of our six live domains passed, against external experts, before release. Co-developed with the Fraunhofer Institute IIS. → How validation works
Your environment, your data
ProxyMed runs where your data lives: on-premise, private cloud, or SaaS. Decision models are deterministic — no open prompts, no text generation — the system processes structured decision criteria only, never patient identifiers or free text.
Security & compliance
Data processing agreement (AVV/DPA) available · Hosting in Switzerland · Technical and organizational measures (TOMs) documented, available on request.
Regulatory pathway
Clinical decision support in the EU is medical-device territory — and ProxyMed’s software architecture is designed from the ground up to comply with MDR (EU) 2017/745: deterministic behavior, full traceability, documented change control, audit-ready records. The conformity route is defined per product and distribution model — as a standalone device, or as the technology component inside a partner’s certification.
Highlights
Structured decision logic
Ordered questioning through every decision-relevant criterion.
Full transparency
Every recommendation traceable to its evidence and its version.
Localized digital twins
Your guidelines, protocols and experts as validated versioned products.
Maintained by design
A guideline update triggers one scoped revalidation round. Cost tracks change, not usage.
Validated end to end
Systematic validation across decision paths against expert judgment.
Deployed your way
Embedded in existing products, on-premise, or SaaS.
From the reference product · a decision product in use
Structured assessment
The product asks only what the decision needs, in clinical order, with scores captured as it goes.
Active, ordered questioning through every decision-relevant criterion, symptom to diagnosis to therapy.
Deterministic result
One recommendation, its decision criteria, its consensus and its source, shown with the answer.
What your organization gains.
Reliability becomes a system property.
The expertise, guidelines and content you already own become deterministic decision products. Every clinician is guided to the individually optimal action: complete inputs, local standards, known evidence base.
Localization becomes economically scalable.
One methodology, many localized models. Each localized product reuses the same production foundation.
A portfolio that grows without proportional effort.
Validation becomes systematic, updates become governed and scoped, and every new product reuses the same production foundation.
Meet the founders.
Both founders hold a doctorate in the natural sciences and a PhD in Molecular Medicine from ETH Zurich — both with research in regenerative stem cell medicine.
Dr. Gregor Bahrenberg
CEO & Co-Founder
From research into life science consulting: strategy work across the life science industry. At ProxyMed, he leads the company, commercial strategy, and partnerships.
LinkedIn →
Dr. Stephan Glanz
CTO & Co-Founder
From research into pharma: medical management and multiple oncology product launches across the EU — bringing regulated, evidence-based clinical products to market. At ProxyMed, he leads product and the clinical decision methodology: how knowledge is modeled, localized, and validated with experts in the loop.
LinkedIn →Localized clinical guidance, economically scalable.
At portfolio scale, validation, localization and continuous updates become an operational challenge. ProxyMed turns that challenge into a repeatable production process.
ProxyMed: from trusted knowledge to trustworthy clinical decision products, through a repeatable production system.